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Abstract 
 Background: The association of Human Immune deficiency 
Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) and sex 
hormone changes may grossly affect the reproductive health in affected 
women. This was a prospective study done at Nnamdi Azikiwe University 
Teaching Hospital Nnewi, Anambra State, Nigeria to evaluate the sex 
hormone changes in HIV infected women of reproductive age group during 
menstrual cycle. Materials and methods: A total of 90 women (60 HIV 
European Scientific Journal June 2015 edition vol.11, No.18  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
135 
positive, 30 Control) were studied. After detailed medical examination, a 
well-structured questionnaire was self-administered.  Blood samples were 
collected under sterile conditions during the follicular and luteal phases of 
menstrual cycle after due informed consent had been sought and obtained. 
The samples were analyzed for sex hormones (Progesterone, estradiol and 
testosterone) using Enzyme Linked Immunosorbent Assay (ELISA) method. 
Results: The result showed that the sex hormones (Progesterone, estradiol 
and testosterone) were significantly lower at both phases of the menstrual 
cycle in HIV infected women when compared to the Control (P<0.05). 
Conclusion: The study revealed some degree of hypogonadism in HIV 
infected women which may have some implication in their reproductive life.  
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Introduction 
 The Human Immune deficiency Virus/Acquired Immune Deficiency 
Syndrome (HIV/AIDS) is a leading cause of morbidity and mortality among 
women of reproductive age in Nigeria (UNAIDS 2011; NACA 2012). 1.72 
million (58%) out of 3.1 million people living with HIV/AIDS in Nigeria are 
females within their reproductive age (15-45 years) (UNAIDS 2011; 
UNAIDS 2012). This shows increased burden of HIV on the female 
population when compared to their male counterparts.  
 HIV has been known to impact negatively on women’s reproductive 
health (Ikechebelu et al., 2002; Fallahian and Ilkhani, 2006). The negative 
reproductive impact ranges from menstrual disorders to outright infertility. 
Some of these disorders may be as a result of deranged ovarian function with 
far reaching effects on sex hormones. 
 The present study was therefore designed to evaluate sex hormones 
changes associated with menstrual cycle in HIV infected premenopausal 
female subjects in Nnewi, Anambra State, Nigeria.  
 
Materials and methods 
 The sample population consisted of ninety premenopausal female 
participants within the age range (15-45years). Thirty participants were 
apparently healthy controls recruited amongst the Hospital staff. Thirty 
participants were HIV seropositive females who have not been placed on 
antiretroviral therapy while the remaining thirty were HIV seropositive 
female participants who have been placed on antiretroviral therapy for not 
less than six months. They were recruited at the HIV clinic of Nnamdi 
Azikiwe University Teaching Hospital Nnewi, Anambra State Nigeria. 
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 After obtaining informed consent of the participants, a well detailed 
questionnaire was administered to each participant to ascertain their medical 
and reproductive history. 8 millimeters of venous blood was collected 
aseptically between 9.00am and 12noon from each participant at follicular 
(7-13th day) and luteal (21-23rd day) phases of menstrual cycle. All the 
participants were double screened for malaria parasite and HIV infection 
using rapid antigen diagnostic techniques for malaria falciparum and 
immunoassay and immunochromatographic methods for HIV screening 
respectively. The serum content was separated immediately after clot 
retraction, labeled and stored at -20oC for determination of estradiol, 
progesterone and testosterone using ELISA (Enzyme Linked Immunosorbent 
Assay) method.  
 The ethics committee of NAUTH Nnewi approved the study design 
and only those who gave their consent were recruited for the study.  
 Inclusion and Exclusion criteria: only the participant adjudged as 
HIV stage 2 were recruited for the study. HIV stage 1, stage 3 and stage 4 
were excluded, participant with malaria parasite infection as at the time of 
study were excluded, participants on contraceptives were excluded, women 
with previous history of infertility prior to the study and participants who 
were co-infected with tuberculosis were also excluded from the study. Hence 
the female participants used were those with no prior fertility problems until 
the existence of HIV infection. 
 
Methods 
 Antibodies to HIV-1 and HIV-2 in Human Plasma were detected 
using Abbott Deterimine system, Immunoassay method [(Trinity Biotech 
UniGold Assay Kit (Trinity Biotech PLC, Ireland)] and 
imunochromatographic method [(HIV 1 and 2 STAT-PAK Assay kit 
(Chembio diagnostic system, INC New York, USA)] respectively. 
 Determination of Progesterone, Estradiol and testosterone were done 
using Enzyme Linked Immunosorbent Assay (ELISA) kits (Glory Science 
Laboratory USA) 
 
Statistical analysis 
 The version 16 of SPSS package was used in statistical analysis. The 
variables were expressed as mean (±SD). The student t-test and analysis of 
variance (ANOVA) and post-hoc (LSD) were used to assess significant mean 
differences. Graph Pad Prism version 5.03 was used for graph presentations. 
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Results 
Levels of Sex Hormone (Progesterone) at follicular and luteal phases of 
menstrual cycle 
 The mean (±SD) serum Progesterone concentration (ng/ml) in HIV 
seropositive females and HIV seropositive females on ART was not 
significantly different between follicular (1.9±0.7, 2.5±2.0) and luteal 
(1.9±0.3, 2.1±1.8) phases of menstrual cycle (P>0.05 respectively). But the 
mean serum progesterone concentration (ng/ml) dropped significantly at 
follicular phase (4.4±2.5) compared with the luteal phase (8.7±4.9) of 
menstrual cycle in Control female subjects (P<0.05).  
 When the mean progesterone concentration (ng/ml) at follicular and 
luteal phases of menstrual cycle were compared between the Control group 
and the Test groups, the mean progesterone concentration dropped 
significantly in HIV seropositive (1.9±0.7, 1.9±0.3) and HIV seropositive on 
ART (2.5±2.0, 2.1±1.8) compared with follicular and luteal values in the 
Control female subjects (4.4±2.5, 8.7±4.9) (P<0.05 respectively) (See Fig 1). 
 
Levels of Sex Hormone (Estradiol) at follicular and luteal phases of 
menstrual cycle 
 The mean (±SD) serum estradiol Concentration (pg/ml) in HIV 
seropositive females and HIV seropositive females on ART was not 
significantly different between follicular (24.2±18.7, 32.8±20.2) and luteal 
(18.7±11.2, 38.4±24.0) phases of menstrual cycle (P>0.05 respectively). 
Conversely, the mean estradiol value (pg/ml) dropped significantly at 
follicular phase (80.9±36.6) compared with luteal phase (94.1±50.1) of 
menstrual cycle in Control female subjects (P<0.05). 
 When the mean estradiol concentration (ng/ml) at follicular and luteal 
phases of menstrual cycle were compared between the Control group and 
Test groups, the mean estradiol dropped significantly in   HIV seropositive 
females (24.2±18.3, 18.7±11.2) and HIV seropositive females on ART 
(32.8±20.2, 38.4±24.0) compared with follicular and luteal values in the 
Control female subjects (80.9±36.6, 94.1±50.1) (P<0.05 respectively) (see 
fig 2). 
 
Levels of Sex Hormone (Testosterone) at follicular and luteal phases of 
menstrual cycle 
 The mean (±SD) serum testosterone level (ng/ml) in HIV 
seropositive females was not significantly different between follicular 
(0.30±0.17) and luteal (0.30±0.15) phases of the cycle (P>0.05). In HIV 
seropositive females on ART, there was no significant difference in the mean 
testosterone concentration (ng/ml) between the follicular (0.41±0.27) and 
luteal (0.36±0.15) phases of menstrual cycle (P>0.05). But the mean serum 
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testosterone value (ng/ml) dropped significantly at luteal (0.81±0.27) phase 
of menstrual cycle compared with follicular phase (1.08±0.48) in the Control 
female subjects (P<0.05). 
 When the Mean Testosterone concentration (ng/ml) at follicular and 
luteal phase of menstrual cycle were compared between the Control group 
and Test groups, the Mean Testosterone level dropped significantly in HIV 
seropositive females (0.30±0.17, 0.30±0.15) and HIV seropositive females 
on ART (0.41±0.27, 0.36±0.15) compared with the corresponding values in 
the Control female subjects (1.08±0.48, 0.81±0.27) (P<0.05 respectively).  
 The pos hoc analysis showed significantly higher mean testosterone 
concentration (pg/ml) at follicular and luteal phases of menstrual cycle in 
HIV seropositive females on ART (0.41±0.27, 0.36±0.15) compared with the 
corresponding values in HIV seropositive female subjects (0.30±0.17, 
0.30±0.15 respectively) (See Fig 3). 
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Discussion  
 The present study showed that the mean serum levels of progesterone 
and estradiol in HIV seropositive females was not significantly different 
between follicular and luteal phases of menstrual cycle. This contrasts the 
observation in apparently healthy subjects where differences in hormonal 
levels exist between the two phases of the menstrual cycle. FSH and LH are 
usually higher at the follicular phase and peak at the mid cycle to enable 
ovulation take place (Norman, 2001) while Progesterone and estradiol are 
usually higher at the luteal phase. The absence of this normal physiological 
balance in the test subjects may cause changes in the cycle which may affect 
reproductive function. Significant reductions in the level of progesterone at 
the luteal phase may disturb the sustenance of pregnancy and lead to 
spontaneous abortion while gross reductions in these hormones 
(hypogonadism) may cause failure of menstruation or significant 
abnormality in menstrual cycle. All these factors may play significant role in 
the pathogenesis of infertility in affected women.  
 The serum levels of progesterone and estradiol levels were 
significantly lower in HIV seropositive and HIV seropositive females on 
ART at both follicular and luteal phases of menstrual cycle. The implication 
of grossly reduced progesterone is primary ovarian failure. This means that 
the anterior pituitary may be overworking itself to stimulate a poorly 
responding ovary. The abnormally low progesterone signifies hypogonadism 
and may lead to menstrual and reproductive failure. Some previous studies 
done developed countries (Merrill et al., 1989; Tracy and Cerami, 1990) 
produced a similar report. Hypogonadism is a significant cause of infertility 
in HIV women (Grinspoon et al., 1997).  
 The appreciation in the level of progesterone in HIV seropositive 
subjects on ART suggests stimulatory effects of the treatment on the gonads 
with intact negative feedback mechanism thereby resulting in the restoration 
of the gonadal functions showing some beneficial effects and a tendency to 
return to normal. This may reduce the incidence of menstrual abnormality 
and infertility. Unfortunately however, studies have reported that prolonged 
use of ART especially protease inhibitors have been associated with other 
problems such as hyper prolactinaemia (Hutchinson et al., 2000).  Hyper 
prolactinaemia has been associated with increased incidence of anovulation 
and hence infertility (Ikechebelu et al., 2002).  
 Studies of ovarian function in HIV infected women have produced 
controversial reports. Whereas some authors (Chargwin et al., 1996; Harlow 
et al., 2000) reported significant effects of HIV on ovarian function, others 
(Shah et al., 1994; Ellerbrock et al., 1996) reported no significant change in 
ovarian function. This controversy is believed to be due to the fact that most 
of the studies were done in advanced or industrialized countries where 
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women who were advanced in age were the participants and the studies did 
not consider the phases of their menstrual cycle. Such women were said to 
have poor ovarian reserve since most of them were premenopausal (Panda et 
al., 2013). In the present study however, the participants were women within 
their reproductive age (15-45years) at different phases of their menstrual 
cycle and the effects of HIV on the ovarian function will be more 
pronounced. 
             The significantly lower level of testosterone observed in HIV 
seropositive and  HIV seropositive female subjects on ART when compared 
to Control females is also due to the reduced ovarian function. In normal 
physiology, testosterone is produced by the ovaries in the females in very 
small quantities which serve to maintain muscle mass and hence prevents 
weight loss. In diseased individuals, this quantity becomes much smaller 
because of reduced ovarian function and is not able to achieve its 
physiological function anymore hence the excess weight loss that is 
associated with these diseases (HIV inclusive) (Huang et al., 2003). 
               In Conclusion, the study showed significant reduction in the sex 
steroid hormones indicating reduced ovarian function (hypogonadism) which 
accounts for menstrual changes that can lead to infertility in the affected 
women.  
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